CXCR6 and metabolic dysfunction-associated steatohepatitis: CXCR6+ CD8+ T cells in murine models of MASH have been shown to upregulate the expression of the exhaustion marker PD1, and subsequent CD8+ T-cell activation via PD-1 blockade exacerbated MASH development [46].